Ondansetron Aristo

Ondansetron, the active ingredient in Ondansetron Aristo, is a serotonin 5‑HT3 receptor antagonist presented as a tablet for oral use. It is employed to prevent nausea and vomiting associated with chemotherapy, radiation therapy, and postoperative recovery in adults and children.

GNH USA supplies Ondansetron Aristo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing consistent quality and regulatory compliance. The company leverages a robust distribution network to ensure timely delivery across multiple continents and adherence to local import regulations.

Ondansetron is a selective 5‑HT3 receptor antagonist used to manage nausea and vomiting across several clinical settings.

- Chemotherapy-induced nausea and vomiting: reduces the frequency and severity of acute and delayed episodes in cancer patients. - Radiation-induced nausea and vomiting: helps control nausea associated with radiotherapy to the abdomen or pelvis. - Postoperative nausea and vomiting: prevents nausea and vomiting after surgical procedures in adults and pediatric patients.

Common Side Effects: - Headache: mild to moderate pain often reported. - Constipation: reduced bowel movements. - Diarrhoea: loose stools. - Fatigue: feeling of tiredness. - Dizziness: light‑headed sensation. - Abdominal discomfort: mild stomach pain.

Serious or Rare Side Effects: - QT prolongation: may lead to cardiac arrhythmias. - Severe allergic reaction: anaphylaxis with rash, swelling, or breathing difficulty. - Serotonin syndrome: rare when combined with other serotonergic drugs. - Hepatic dysfunction: abnormal liver enzymes. - Cardiac arrhythmia: irregular heart rhythm beyond QT issues.

Precautions should be observed before initiating therapy. - Cardiac assessment: evaluate ECG in patients with known QT prolongation. - Concomitant medications: avoid or monitor drugs that also prolong QT interval. - Hepatic impairment: use with caution and consider dose adjustment. - Pregnancy and lactation: prescribe only if benefit outweighs potential risk. - Allergic reactions: discontinue immediately if signs of severe hypersensitivity appear. - Store at room temperature: keep below 25 °C in the original packaging, protect from moisture and light.

Ondansetron may interact with several medicines.

Major Interactions (Avoid): - Apomorphine: can cause severe hypotension. - Certain antiarrhythmics (e.g., amiodarone): increase risk of QT prolongation. - Other 5‑HT3 antagonists: no additive benefit and may raise plasma levels.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole): may increase ondansetron concentrations. - CYP3A4 inducers (e.g., rifampin): may reduce effectiveness. - Anticholinergic agents: may exacerbate constipation. - Opioids: heightened risk of constipation. - Serotonergic antidepressants: monitor for serotonin syndrome.